Pharmaron Beijing IPO: H-Share Valuation Enticing
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
586 Views
Pharmaron (康龙化成) A+H: Decent H/A Discount and Cornerstone Line-Up
Pharmaron, the secondly largest CRO based in China, launched book building today to raise up to USD 588 million to list in Hong Kong. In our...
567 Views